Griffin Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,228
| Closed | -$444K | – | 216 |
|
|
2024
Q2 | $444K | Sell |
8,228
-2,250
| -21% | -$122K | 0.05% | 163 |
|
|
2024
Q1 | $714K | Buy |
10,478
+25
| +0.2% | +$1.7K | 0.09% | 149 |
|
|
2023
Q4 | $654K | Buy |
10,453
+352
| +3% | +$22K | 0.08% | 155 |
|
|
2023
Q3 | $458K | Buy |
10,101
+6,359
| +170% | +$289K | 0.07% | 163 |
|
|
2023
Q2 | $210K | Buy |
+3,742
| New | +$210K | 0.03% | 205 |
|
|
2021
Q4 | – | Sell |
-3,082
| Closed | -$345K | – | 237 |
|
|
2021
Q3 | $345K | Sell |
3,082
-2,244
| -42% | -$251K | 0.04% | 194 |
|
|
2021
Q2 | $862K | Buy |
5,326
+3,550
| +200% | +$575K | 0.1% | 150 |
|
|
2021
Q1 | $216K | Buy |
+1,776
| New | +$216K | 0.03% | 226 |
|
|
2019
Q3 | – | Sell |
-1,360
| Closed | -$64K | – | 281 |
|
|
2019
Q2 | $64K | Buy |
+1,360
| New | +$64K | 0.01% | 335 |
|